Literature DB >> 32992011

Dengue viremia kinetics in asymptomatic and symptomatic infection.

Ponpan Matangkasombut1, Kajohnpong Manopwisedjaroen2, Nada Pitabut3, Sasikanya Thaloengsok2, Swangjit Suraamornkul4, Tawatchai Yingtaweesak5, Veasna Duong6, Anavaj Sakuntabhai7, Richard Paul7, Pratap Singhasivanon8.   

Abstract

BACKGROUND: Dengue infection is a global health threat. While symptomatic cases contribute to morbidity and mortality, the majority of infected people are asymptomatic but serve as an important reservoir. However, the kinetics of viremia in asymptomatic infections remains unknown.
METHODS: We enrolled 279 hospital-based symptomatic index cases and quantified dengue virus (DENV) RNA at enrollment and at the day of defervescence. To identify asymptomatic cases, 175 household members of index cases were monitored for clinical symptoms during follow-up, and blood was taken twice weekly to test for and quantify DENV RNA until cleared.
RESULTS: We detected DENV in thirteen asymptomatic household members (7.43%). Their DENV serotypes were primarily the same as those of their family index cases. The median peak DENV viremia in asymptomatic subjects was lower than that of symptomatic individuals during the febrile phase, and the viral decay rate was slower in asymptomatic infections.
CONCLUSIONS: DENV level and kinetics in asymptomatic individuals differed significantly from those of symptomatic cases. Despite the lower viremia, the slower decay rate in asymptomatic infections could lead to their prolonging the infectious reservoir. The improvement of transmission control to prevent such long-lived asymptomatic infections from transmitting the DENV is needed.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Asymptomatic; Dengue; Inapparent; Viral decay; Viremia duration; Virus kinetics

Mesh:

Year:  2020        PMID: 32992011     DOI: 10.1016/j.ijid.2020.09.1446

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  7 in total

1.  A multiple-target mRNA-LNP vaccine induces protective immunity against experimental multi-serotype DENV in mice.

Authors:  Lihong He; Wenqiang Sun; Limin Yang; Wenjun Liu; Jing Li
Journal:  Virol Sin       Date:  2022-07-12       Impact factor: 6.947

2.  Dengue Seroprevalence and Factors Associated with Dengue Seropositivity in Petaling District, Malaysia.

Authors:  Rui Jie Ng; Zhuo Lin Chong; Mohd Hatta Abdul Mutalip; Chiu-Wan Ng
Journal:  Int J Environ Res Public Health       Date:  2022-06-11       Impact factor: 4.614

3.  Tree Shrew as a New Animal Model for the Study of Dengue Virus.

Authors:  Liming Jiang; Caixia Lu; Qiangming Sun
Journal:  Front Immunol       Date:  2021-03-25       Impact factor: 7.561

4.  Lack of Association between Adverse Pregnancy Outcomes and Zika Antibodies among Pregnant Women in Thailand between 1997 and 2015.

Authors:  Nicole Ngo-Giang-Huong; Charline Leroi; Dahlene Fusco; Tim R Cressey; Nantawan Wangsaeng; Nicolas Salvadori; Natedao Kongyai; Wasna Sirirungsi; Marc Lallemant; Prasert Auewarakul; Woottichai Khamduang; Gonzague Jourdain
Journal:  Viruses       Date:  2021-07-22       Impact factor: 5.048

5.  Single-cell temporal analysis of natural dengue infection reveals skin-homing lymphocyte expansion one day before defervescence.

Authors:  Jantarika Kumar Arora; Anunya Opasawatchai; Tiraput Poonpanichakul; Natnicha Jiravejchakul; Waradon Sungnak; Oranart Matangkasombut; Sarah A Teichmann; Ponpan Matangkasombut; Varodom Charoensawan
Journal:  iScience       Date:  2022-03-05

6.  Usage of FTA® Classic Cards for Safe Storage, Shipment, and Detection of Arboviruses.

Authors:  Janina Krambrich; Emelie Bringeland; Jenny C Hesson; Tove Hoffman; Åke Lundkvist; Johanna F Lindahl; Jiaxin Ling
Journal:  Microorganisms       Date:  2022-07-18

7.  Innate Lymphoid Cells Activation and Transcriptomic Changes in Response to Human Dengue Infection.

Authors:  Tiraput Poonpanichakul; Wilawan Chan-In; Anunya Opasawatchai; Fabien Loison; Oranart Matangkasombut; Varodom Charoensawan; Ponpan Matangkasombut
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.